Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
2015 ◽
Vol 130
(5)
◽
pp. 713-729
◽
2021 ◽
Vol 19
(2)
◽
pp. 147-156
2019 ◽
Vol 78
(2)
◽
pp. 101-112
◽
Keyword(s):
Keyword(s):
2004 ◽
Vol 369
(3)
◽
pp. 219-223
◽
1998 ◽
Vol 105
(4)
◽
pp. 415
◽
1996 ◽
Vol 67
(4)
◽
pp. 429-429
◽
2015 ◽
Vol 129
(5)
◽
pp. 757-762
◽
2011 ◽
Vol 95
(4)
◽
pp. 547-556
◽
2000 ◽
Vol 35
(9-10)
◽
pp. 1363-1372
◽